MedPath

NANOPASS TECHNOLOGIES LTD

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

2 Phases

Early Phase 1:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (66.7%)
Early Phase 1
1 (33.3%)

A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle

Early Phase 1
Completed
Conditions
Intradermal Injections
First Posted Date
2008-01-28
Last Posted Date
2013-05-10
Lead Sponsor
NanoPass Technologies Ltd
Target Recruit Count
23
Registration Number
NCT00602914

A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines

Not Applicable
Completed
Conditions
Influenza, Human
First Posted Date
2007-11-15
Last Posted Date
2013-05-10
Lead Sponsor
NanoPass Technologies Ltd
Target Recruit Count
180
Registration Number
NCT00558649

A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia

Not Applicable
Completed
Conditions
Local Anesthesia
Intradermal Injections
First Posted Date
2007-10-03
Last Posted Date
2013-05-10
Lead Sponsor
NanoPass Technologies Ltd
Target Recruit Count
40
Registration Number
NCT00539084

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.